Lost Money on Vistagen Therapeutics, Inc.(VTGN)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 6, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vistagen Therapeutics, Inc. ("Vistagen Therapeutics, Inc.") (NASDAQ:VTGN) concerning possible violations of federal securities laws.

On December 17, 2025, before the market opened, Vistagen announced topline results from its PALISADE-3 Public Speaking Challenge Study of fasedienol for the acute treatment of social anxiety disorder (SAD).

The company reported that the study failed to meet its primary efficacy endpoint since it "did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placebo."

Following this news, VTGN's stock price fell over 81% to open at $0.88 per share. To obtain additional information, go to:

https://zlk.com/pslra-1/vistagen-therapeutics-inc-lawsuit-submission-form?prid=182681&wire=1

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212)363-7500

Fax: (212)363-7171

https://zlk.com/

SOURCE: Levi & Korsinsky, LLP